SCHEMBL359090

SCHEMBL359090

SC1SC=CS1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17179506 0.57
SCHEMBL3069173 0.56
SCHEMBL9481507 0.55
SCHEMBL4864400 0.55
SCHEMBL11481817 0.55
SCHEMBL135302 0.55
SCHEMBL430501 0.53
SCHEMBL3316032 0.52
SCHEMBL1025720 0.46
SCHEMBL561897 0.41

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105413854-B Beneficiation method for high-oxidation-rate copper-molybdenum paragenic ore 中国地质科学院矿产综合利用研究所 2018-02-13 CN claimed
CN-105413854-A Beneficiation method for high-oxidation-rate copper-molybdenum paragenic ore INST OF MULTIPURPOSE UTILIZATION OF MINERAL RESOURCES CHINESE ACAD OF GEOLOGICAL SCIENCES 2016-03-23 CN claimed
US-12569456-B2 Methods for the treatment of cysteamine sensitive disorders THIOGENESIS THERAPEUTICS, INC. (US) 2026-03-10 US disclosed
EP-4534527-A2 METHODS FOR THE TREATMENT OF CYSTEAMINE SENSITIVE DISORDERS Thiogenesis Therapeutics, Inc. (US) 2025-04-09 EP disclosed
EP-3684418-B1 COMPOUNDS FOR THE TREATMENT OF CYSTEAMINE SENSITIVE DISORDERS THIOGENESIS THERAPEUTICS INC (US) 2025-02-12 EP disclosed
CN-118924717-A Methods for treating cysteamine-sensitive disorders 硫创治疗公司 2024-11-12 CN disclosed
CN-111683684-B Methods for treating cysteamine-sensitive disorders 硫创治疗公司 2024-07-02 CN disclosed
CN-117599029-A Compositions for controlled release of cysteamine and systematic treatment of cysteamine-sensitive disorders 硫创治疗公司 2024-02-27 CN disclosed
CN-117199251-A Battery material, negative electrode, battery and battery preparation method 星欧光学股份有限公司 2023-12-08 CN disclosed
US-11786491-B2 Compositions for controlled release of cysteamine and systemic treatment of cysteamine sensitive disorders THIOGENESIS THERAPEUTICS, INC. (US) 2023-10-17 US disclosed
US-20230190683-A1 METHODS FOR THE TREATMENT OF CYSTEAMINE SENSITIVE DISORDERS THIOGENESIS THERAPEUTICS, INC. 2023-06-22 US disclosed
US-20040016910-A1 Non-toxic corrosion-protection rinses and seals based on rare earth elements DAYTON, UNIVERSITY OF 2004-01-29 US disclosed
US-20040011252-A1 Non-toxic corrosion-protection pigments based on manganese UNIVERSITY OF DAYTON 2004-01-22 US disclosed
US-20030234063-A1 Non-toxic corrosion-protection conversion coats based on cobalt DAYTON, UNIVERSITY OF 2003-12-25 US disclosed
US-20030230363-A1 Non-toxic corrosion-protection rinses and seals based on cobalt UNIVERSITY OF DAYTON 2003-12-18 US disclosed
WO-2003060192-A1 NON-TOXIC CORROSION-PROTECTION RINSES AND SEALS BASED ON COBALT UNIVERSITY OF DAYTON (US) 2003-07-24 WO disclosed
WO-2003060191-A2 NON-TOXIC CORROSION-PROTECTION CONVERSION COATINGES ABSED ON COBALT UNIVERSITY OF DAYTON (US) 2003-07-24 WO disclosed
WO-2003060019-A1 NON-TOXIC CORROSION PROTECTION PIGMENTS BASED ON COBALT UNIVERSITY OF DAYTON (US) 2003-07-24 WO disclosed
CN-1046275-C 2-methoxyiminophenyl-N-methylacetamide derivatives, process for their preparation, their use and compositions containing them BASF AG (DE) 1999-11-10 CN disclosed
CN-1118165-A Ortho-substituted 2-methoxyiminophenylacetic acid methylamides BASF AG (DE) 1996-03-06 CN disclosed